Liquid biopsies and other novel techniques have the potential to change the bladder cancer space. However, unanswered questions remain.
Being an advocate might not only change your patients' lives but your life as well.
Morganna Freeman discusses how nurses can prepare for side effect management in clinical trials.
Ignacio I. Wistuba, MD, chair of the department of Translational Molecular Pathologies at MD Anderson Cancer Center, discusses the role nurses play in the field of molecular testing.
Cancer and its treatment creates or aggravates psychosocial distress, while unresolved physical and practical problems can also add to the distress of patients attempting to complete their treatment and recovery.
ASCO releases new recommendations amid growing therapeutic options and fresh concerns about serious skeletal-related events.
Mark Kris, MD, William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, discusses the benefits of new therapies for lung cancer.Â
Karen Lee, NP, explains the importance of keeping patients with cancer hopeful but realistic when starting immunotherapies.
Joanne McGovern, MSN, RN, CCRN, offers some tips on how to encourage nurses to create and implement their own research projects.
New targeted therapies offer certain patients with non–small cell lung cancer more second-line treatment options.
Genetic testing can be very beneficial to patients and their families. However, some people are still unsure about having it done.
Nina Grenon, RN, APRN, BC, nurse practitioner, Dana-Farber Cancer Institute, discusses the results of a study that looked at the effect of palliative care in patients with lung cancer.
Penny Daugherty, RN, MSN, OCN, of Northside Hospital Cancer Institute, discusses the harmful and confusing misinformation that surrounds medical marijuana.
Results from the randomized phase 3 POLO trial are in, and the quality of life data shows promise for patients with metastatic pancreatic cancer who harbor a germline BRCA gene mutation.
In order to give life to a strategy, a nurse leader must understand the clinical environment and how patients and staff respond to various interventions.
Dennise Geiger, RN, Regional Cancer Care Associates, Central Jersey Division, discusses difficulties nurses face when using telephone triage, and the plan that was developed to better streamline the process.
Jennifer Klemp, PhD, MPH, discusses the importance of measuring outcomes in survivorship care for patients with cancer.
Gwen Wyatt, PhD, RN, FAAN,discusses the challenges associated with conducting a multisite randomized clinical trial.
Rudolph Navari, MD, PhD, professor of Medicine at Indiana University School of Medicine -South Bend, discusses traditional antiemetic treatment for chemotherapy-induced nausea and vomiting (CINV).
A phase III study found that adding 2 years of ovarian function suppression to tamoxifen extended disease-free survival in certain patients with hormone receptor-positive breast cancer.
Joni Watson, MBA, MSN, RN, OCN, Director, Baylor Scott & White Cancer Center, discusses the opportunities Twitter can provide for oncology nurses.
Using mobile apps and other new technologies, clinicians can better monitor and help their patients.
Researchers conducted interviews of patients’ decision-makers to determine how well their understanding of a patient’s prognosis aligned with the physician’s prognostic estimate. The patients were receiving care in the intensive care unit and were identified by physicians as having a high risk of death.
Marie Wood, MD, medical oncologist, University of Vermont, discusses the correlation between aspirin use and lower breast density.
Collaboration to feature content from one of nation’s leading nursing school programs.
There is a growing buzzword in the medical industry, and it is oncology rehabilitation.
Men tend not to seek help for psychosocial issues and notably less often than women do.